Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Receivables (2022 - 2025)

Neuraxis' Receivables history spans 4 years, with the latest figure at $327919.0 for Q3 2025.

  • For Q3 2025, Receivables rose 42.14% year-over-year to $327919.0; the TTM value through Sep 2025 reached $327919.0, up 42.14%, while the annual FY2024 figure was $338969.0, 57.73% up from the prior year.
  • Receivables for Q3 2025 was $327919.0 at Neuraxis, up from $233077.0 in the prior quarter.
  • Across five years, Receivables topped out at $442853.0 in Q1 2025 and bottomed at $132382.0 in Q3 2023.
  • The 4-year median for Receivables is $233077.0 (2025), against an average of $256725.5.
  • The largest annual shift saw Receivables fell 19.93% in 2023 before it surged 164.52% in 2025.
  • A 4-year view of Receivables shows it stood at $268406.0 in 2022, then decreased by 19.93% to $214908.0 in 2023, then soared by 57.73% to $338969.0 in 2024, then dropped by 3.26% to $327919.0 in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Receivables are $327919.0 (Q3 2025), $233077.0 (Q2 2025), and $442853.0 (Q1 2025).